ADAPT 2011
7-9 September, 2011 | Loews Philadelphia Hotel, Philadelphia, PA

  Old notions of personalized medicine are changing

from nice to have, to necessary to have   

The benefits to the patient, as well as the business opportunities a targeted therapy approach present are driving this change. The ADAPT 2011 Congress brings together senior executives and key strategic players from across Pharma, Diagnostic, Clinical and Informatics to work together to shape the future of personalized medicine towards a targeted approach. Case studies, discussion groups, short courses and technology highlights will explore the relationship between biomarkers and the promise of personalized therapy, how circulating tumor cells (CTCs) could better track the progression of cancer, and adaptive trials that bring targeted therapies to market.

We hope to see you in Philadelphia. 

Conference Highlights

• Network with 400+ colleagues
• Hear 80 in-depth case studies and case histories
• Choose from 7 educational short courses*

* Separate Registration Required

Lukas Amler
Director,
Genentech

Abdel Halim
Director, Daiichi
Sankyo, Pharma Development

Jeffrey Jackson
Group Director,
Bristol-Myers Squibb

Francesco Marincola
Associate Director,
Trans-NIH Center for Human Immunology,
NIH

Stafford O'Kelly
President,
Abbott Molecular

Jerald Schindler
Vice President,
Merck

Werner Verbiest
Head, Companion Diagnostics,
Center of Excellence,
Johnson & Johnson